Skip to main content
Elsevier
View Cart
My account

Books in Pharmaceutical sciences

Elsevier's Pharmaceutical Sciences collection helps pharmaceutical scientists striving to optimize drug design and improve healthcare outcomes by offering comprehensive coverage of every aspect of drug development, integrating disciplines like organic chemistry, biology, and biotechnology. Focused on safety, efficacy, and formulation design, it includes specialized fields such as Clinical Pharmacology and Translational Research, providing valuable insights into the latest advancements in drug discovery.

BooksJournals

    • Medicinal Chemistry of Anticancer Drugs

      • 1st Edition
      • April 9, 2008
      • Carmen Avendaño + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 4 5 2 8 2 4 7
      • eBook
        9 7 8 0 0 8 0 5 5 9 6 2 9
      Antitumor chemotherapy is nowadays a very active field of research, and a huge amount of information on the topic is generated every year. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book addresses the need for an updated treatment from the point of view of medicinal chemistry and drug design. The focus of Medicinal Chemistry of Anticancer Drugs is on the mechanism of action of antitumor drugs from the molecular point of view and on the relationship between chemical structure and chemical and biochemical reactivity of antitumor agents, aiming at the rationalization of the action of this type of drug, which would allow the design of new active structures.

    • Side Effects of Drugs Annual

      • 1st Edition
      • Volume 29
      • May 9, 2007
      • Jeffrey K. Aronson
      • English
      • Hardback
        9 7 8 0 4 4 4 5 1 9 8 6 3
      • eBook
        9 7 8 0 0 8 0 5 2 2 8 1 4
      The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has contributed to the Annuals by selecting critically from each year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is misleading.

    • Advances in Antiviral Drug Design

      • 1st Edition
      • Volume 5
      • July 30, 2007
      • E. De Clercq
      • English
      • Hardback
        9 7 8 0 4 4 4 5 2 1 7 3 6
      • Paperback
        9 7 8 0 4 4 4 5 6 1 0 3 9
      • eBook
        9 7 8 0 0 8 0 5 4 8 2 4 1
      Regularly reviewing the "state-of-the-art" developments in the antiviral drug research field, this latest volume spans the conceptual design and chemical synthesis of new antiviral compounds. It discusses their structure-activity relationship, mechanism and targets of action, pharmacological behavior, antiviral activity spectrum, and therapeutic potential for clinical use.

    • HPLC Method Development for Pharmaceuticals

      • 1st Edition
      • Volume 8
      • May 15, 2007
      • Satinder Ahuja + 1 more
      • English
      • Hardback
        9 7 8 0 1 2 3 7 0 5 4 0 2
      • eBook
        9 7 8 0 0 8 0 5 5 4 1 9 8
      High pressure, or high performance, liquid chromatography (HPLC) is the method of choice for checking purity of new drug candidates, monitoring changes during scale up or revision of synthetic procedures, evaluating new formulations, and running control/assurance of the final drug product. HPLC Method Development for Pharmaceuticals provides an extensive overview of modern HPLC method development that addresses these unique concerns. Includes a review and update of the current state of the art and science of HPLC, including theory, modes of HPLC, column chemistry, retention mechanisms, chiral separations, modern instrumentation (including ultrahigh-pressure systems), and sample preparation. Emphasis has been placed on implementation in a pharmaceutical setting and on providing a practical perspective. HPLC Method Development for Pharmaceuticals is intended to be particularly useful for both novice and experienced HPLC method development chemists in the pharmaceutical industry and for managers who are seeking to update their knowledge.

    • Elsevier's Dictionary of Vitamins and Pharmacochemistry

      • 1st Edition
      • December 4, 2006
      • Henry Philippsborn
      • English
      • Hardback
        9 7 8 0 4 4 4 5 1 6 6 0 2
      • eBook
        9 7 8 0 0 8 0 4 8 8 7 9 0
      The dictionary will contain terms covering the following fields and subfields: Vitamin Technology: Vitamin biochemistry / Physiology; Origin of vitamins: natural, synthetic; Fat-soluble vitamins; Water-soluble vitamins; Vitamins as antioxidants; Vitamin deficiencies / Hypervitaminosis - Enzymes/Proteins: Biotechnology as applied biological science aimed at industrial exploitation - Hormones: Biochemistry; Physiology - Pharmaceutical Chemistry / Pharmaceutical Technology / Pharmaceutical Processes: Conception of the active principles; Structural analysis; Antibiotics and their way of action; Biochemistry; The Drug / The Medicament: Definition, origin, way of action; Biochemistry - Medical Aspects in the languages English, German, French and Portuguese.

    • Pharmacy Law and Practice

      • 4th Edition
      • July 10, 2006
      • Jon Merrills + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 4 5 2 2 0 1 6
      • eBook
        9 7 8 0 0 8 0 4 7 9 9 6 5
      Suitable for both students and practicing pharmacists, the latest edition of this classic textbook provides comprehensive coverage of an essential component of the U.K. pharmacy curriculum: pharmacy law and ethics. Completely rewritten since the last edition to reflect the rapid pace at which this field moves, it offers a clear, readable and non-technical guide on balancing the needs of patients with the letter of the law. It explains what happens and why in a reader-friendly format, taking a problem solving approach, and even provides an introduction to pharmacy issues for solicitors and legal personnel. Any pharmacist, student, or regulatory authority will find it appropriate for either a serious study or for answering questions which occur in practice.

    • Synthesis of Essential Drugs

      • 1st Edition
      • March 10, 2006
      • Ruben Vardanyan + 1 more
      • English
      • Hardback
        9 7 8 0 4 4 4 5 2 1 6 6 8
      • eBook
        9 7 8 0 0 8 0 4 6 2 1 2 7
      Synthesis of Essential Drugs describes methods of synthesis, activity and implementation of diversity of all drug types and classes. With over 2300 references, mainly patent, for the methods of synthesis for over 700 drugs, along with the most widespread synonyms for these drugs, this book fills the gap that exists in the literature of drug synthesis. It provides the kind of information that will be of interest to those who work, or plan to begin work, in the areas of biologically active compounds and the synthesis of medicinal drugs. This book presents the synthesis of various groups of drugs in an order similar to that traditionally presented in a pharmacology curriculum. This was done with a very specific goal in mind – to harmonize the chemical aspects with the pharmacology curriculum in a manner useful to chemists. Practically every chapter begins with an accepted brief definition and description of a particular group of drugs, proposes their classification, and briefly explains the present model of their action. This is followed by a detailed discussion of methods for their synthesis. Of the thousands of drugs existing on the pharmaceutical market, the book mainly covers generic drugs that are included in the WHO’s Essential List of Drugs. For practically all of the 700+ drugs described in the book, references (around 2350) to the methods of their synthesis are given along with the most widespread synonyms. Synthesis of Essential Drugs is an excellent handbook for chemists, biochemists, medicinal chemists, pharmacists, pharmacologists, scientists, professionals, students, university libraries, researchers, medical doctors and students, and professionals working in medicinal chemistry.

    • Drug Discovery

      • 1st Edition
      • December 15, 2005
      • Tamas Bartfai + 1 more
      • English
      • Paperback
        9 7 8 0 1 2 3 6 9 5 3 3 8
      • eBook
        9 7 8 0 0 8 0 9 1 9 2 3 2
      Everyone expects something from the drug industry. Physicians and patients, investors, regulators and administrators all have an active interest. Everyone wants to know what makes drugs ‘work’ medically and economically. Why are drugs so expensive? Is it the drug companies or investors who demand high profits? What governs the pharmacoeconomics? Why are so few diseases treatable? Drug Discovery opens the windows and doors of the industry telling the story of drug development by using real stories from inside the process.

    • Progress in Medicinal Chemistry

      • 1st Edition
      • Volume 43
      • April 16, 2005
      • English
      • Hardback
        9 7 8 0 4 4 4 5 1 5 7 2 8
      • eBook
        9 7 8 0 0 8 0 9 3 0 6 0 2
      The Progress in Medicinal Chemistry series spans a wide range of topics of interest to the drug discovery community. This particular volume touches upon the following:* The Herg ion channel * Fluorescence-based high throughput assay * Aprepitant and neurokinin receptors * Muscarinic receptor targets * Gene activation pathways * Malaria and antimalarial drugs * HIV virus mutation and new therapeuticsProgress in Medicinal Chemistry is available online on ScienceDirect — full-text online of volumes 41 onwards. Elsevier book series on ScienceDirect gives multiple users throughout an institution simultaneous online access to an important compliment to primary research. Digital delivery ensures users reliable, 24-hour access to the latest peer-reviewed content. The Elsevier book series are compiled and written by the most highly regarded authors in their fields and are selected from across the globe using Elsevier’s extensive researcher network. For more information about the Elsevier Book Series on ScienceDirect Program, please visit:http://www.inf...

    • Amylin

      • 1st Edition
      • Volume 52
      • December 12, 2005
      • Andrew Young
      • English
      • Hardback
        9 7 8 0 1 2 0 3 2 9 5 4 0
      • Paperback
        9 7 8 0 1 2 4 1 1 1 3 6 3
      • eBook
        9 7 8 0 0 8 0 9 1 6 0 6 4
      Amylin deciphers amylin's physiology and reveals previously unrecognized mechanisms fundamental to control body weight and fuel homeostasis. This book also discusses therapeutic utility of amylin as the first new medicine to treat diabetes since insulin.

Related subjects

Drug delivery

Drug design

Drug dispensing

Drug manufacturing and packaging

Drug metabolism disposition

Pharmaceutical analysis

Pharmaceutical biotechnology

Pharmaceutical quality control

Pharmaceutical science general

Pharmaceutical technology

Pharmacoeconomics

Pharmacoepidemiology

Pharmacotherapy

Pharmacy

Pharmacy management